PCA Investment Advisory Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,971
Closed -$109K 333
2023
Q2
$109K Buy
+2,971
New +$116K 0.07% 184

Other funds holding PFE

PCA Investment Advisory Services's PFE Position: Q3 2023 in Review

PCA Investment Advisory Services sold out of Pfizer (PFE) in Q3 2023, closing a stake of 2,971 shares — an estimated $109K sold.

PCA Investment Advisory Services first reported a position in PFE in Q2 2023 and held it in 1 quarter. The position peaked at $109K in Q2 2023. 2,926 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

  • PCA Investment Advisory Services reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
  • PCA Investment Advisory Services sold 2,971 Pfizer shares in Q3 2023, an estimated $109K.
  • PCA Investment Advisory Services first reported a position in Pfizer in Q2 2023 and held it in 1 quarter.
  • PCA Investment Advisory Services's Pfizer position peaked at $109K in Q2 2023.
  • 2,926 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on PCA Investment Advisory Services's 13F filing for Q3 2023, filed 13 Nov 2023.